EQUITEC PROPRIETARY MARKETS, LLC
Position in ESPR — Esperion Therapeutics, Inc.
CIK 1143261
CHICAGO, IL
Position in ESPR
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,092,728
New position
Shares Held
345,800
first reported quarter
Ownership
0.134%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#6
of 40 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in ESPR
reported options exposure · as of Jun 30, 2026CallValue
$449,036
CallShares
142,100
PutValue
$1,061,128
PutShares
335,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026EQUITEC PROPRIETARY MARKETS, LLC holds $1,092,728 across 1 Drug Manufacturers - Specialty & Generic name. ESPR ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ESPR |
Esperion Therapeutics, Inc.
This page
|
345,800 | $1,092,728 |
All Filings in ESPR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,061,128 | 335,800 | Put | Sole | 2026-07-20 | |
| 2026-06-30 | $449,036 | 142,100 | Call | Sole | 2026-07-20 | |
| 2026-06-30 | $1,092,728 | 345,800 | Shares | Sole | 2026-07-20 | |
| No filing history on record for this holder in this stock. | ||||||